Since GALNT1 generates the Tn antigen that is widely reported to be predominantly expressed in cancer cells [17,18], there is clinical interest in investigating cellular expression levels in the tumor microenvironment (TME) of breast cancer patients, utilizing single-cell sequence cohorts. The gene discussed is GALNT1; the disease is cancer.